08-MAY-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1157 22 1148 109 1327 231 1406
ERLYTX 80 1 52 9 110 20 122
GI 181 3 157 12 146 28 170
GU 358 7 365 24 292 46 280
LEUK 150 4 209 16 195 29 177
LUNG 193 1 52 10 122 34 207
LYMPH 409 14 730 53 645 92 560
MELAN 147 0 0 0 0 0 0
MMYEL 111 1 52 9 110 22 134
MULT 40 1 52 5 61 14 85
OTHER 54 0 0 4 49 11 67
SXQOL 1 0 0 0 0 0 0
Total 2881 54 2817 251 3057 527 3208

08-MAY-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 158 8 417 21 256 37 225
ERLYTX 10 0 0 1 12 3 18
GU 3 0 0 0 0 3 18
LEUK 633 10 522 59 718 114 694
LUNG 366 6 313 26 317 64 390
OTHER 36 0 0 4 49 6 37
PEOLC 110 0 0 0 0 1 6
PREV 220 3 157 25 304 43 262
SXQOL 614 19 991 63 767 129 785
Total 2150 46 2400 199 2423 400 2435

08-MAY-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1157 22 1148 109 1327 231 1406
CCD 158 8 417 21 256 37 225
ERLYTX 90 1 52 10 122 23 140
GI 181 3 157 12 146 28 170
GU 361 7 365 24 292 49 298
LEUK 783 14 730 75 913 143 871
LUNG 559 7 365 36 438 98 597
LYMPH 409 14 730 53 645 92 560
MELAN 147 0 0 0 0 0 0
MMYEL 111 1 52 9 110 22 134
MULT 40 1 52 5 61 14 85
OTHER 90 0 0 8 97 17 103
PEOLC 110 0 0 0 0 1 6
PREV 220 3 157 25 304 43 262
SXQOL 615 19 991 63 767 129 785
Total 5031 100 5216 450 5478 927 5642

08-MAY-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 730 13 678 63 767 132 804
ERLYTX 49 1 52 8 97 16 97
GI 133 3 157 10 122 23 140
GU 283 7 365 18 219 36 219
LEUK 94 3 157 10 122 19 116
LUNG 121 1 52 5 61 20 122
LYMPH 268 7 365 30 365 58 353
MELAN 97 0 0 0 0 0 0
MMYEL 68 0 0 4 49 12 73
MULT 15 0 0 0 0 5 30
OTHER 54 0 0 4 49 11 67
SXQOL 1 0 0 0 0 0 0
Total 1913 35 1826 152 1851 332 2021

08-MAY-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 130 4 209 13 158 24 146
ERLYTX 10 0 0 1 12 3 18
GU 3 0 0 0 0 3 18
LEUK 271 4 209 20 244 48 292
LUNG 227 3 157 15 183 33 201
OTHER 36 0 0 4 49 6 37
PEOLC 80 0 0 0 0 1 6
PREV 220 3 157 25 304 43 262
SXQOL 441 16 835 46 560 100 609
Total 1418 30 1567 124 1510 261 1589

08-MAY-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 910 20 1044 80 974 159 968
CCD 164 8 417 17 207 38 231
ERLYTX 59 1 52 9 110 19 116
GI 137 3 157 11 134 24 146
GU 315 7 365 14 170 46 280
LEUK 366 7 365 30 365 68 414
LUNG 367 4 209 29 353 65 396
LYMPH 268 7 365 30 365 58 353
MELAN 97 0 0 0 0 0 0
MMYEL 68 0 0 4 49 12 73
MULT 37 0 0 0 0 5 30
OTHER 226 0 0 8 97 30 183
PEOLC 79 0 0 1 12 2 12
PREV 220 3 157 25 304 43 262
SXQOL 442 16 835 46 560 100 609
Total 3755 76 3966 304 3700 669 4073

08-MAY-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 969 17 887 95 1157 210 1278
ERLYTX 74 1 52 9 110 17 103
GI 105 2 104 6 73 15 91
GU 234 6 313 22 268 35 213
LEUK 116 3 157 12 146 24 146
LUNG 163 1 52 10 122 32 195
LYMPH 340 13 678 50 609 81 493
MMYEL 97 1 52 8 97 20 122
MULT 40 1 52 5 61 14 85
Total 2138 45 2347 217 2643 448 2726

08-MAY-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1956 34 1774 159 1936 346 2106
AFFIL 138 6 313 12 146 23 140
CCOP/NCORP 1237 25 1304 105 1278 224 1364
Non-SWOG 1699 34 1774 173 2106 333 2027
Total 5030 99 5165 449 5466 926 5637

08-MAY-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GU S2419 Renal, adv clear cell, IO +/- Biotx, BIOFRONT 1 Y 22-APR-26

08-MAY-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GU NRGGU008 Pros,Node+, Abiraterone acetate + Apalutamide 1 E 15-APR-26
BREAST NRGBR007 Breast, Stg I, De-Escalation of Breast RT 1 E 08-APR-26
BREAST NRGBR007 Breast, Stg I, De-Escalation of Breast RT 2 E 08-APR-26
LUNG S1933 NSCLC, Stg II-III, RT + Atezo 2 N 01-MAY-26

08-MAY-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 16
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 13
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 10
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 10
CCD S2417CD Colrec Surv, Follow-up w/ CTAC site 1 8
SXQOL NRGCC015 E-Mindfulness After Breast Cancer 1 7
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 7
LUNG LUNGMAP NSCLC, Adv, Master 1 6
LUNG LUNGMAP NSCLC, Adv, Master 2 5
CCD S1703 Met Breast, STM-monitoring v Usual Care 1 5
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 5
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 2 4
MMYEL S1803 MM, Maintenance, Len vs Len/Dara 3 4
BREAST A012301 Breast, Early Stg, Tamoxifen 1 3
PREV NRGCC005 Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs 1 3
GU S1802 Pros, Stg IV, SST ± Surg/RT to Primary Tum 1 3
LYMPH S2114 NHL, Rel/Ref, CD19 CAR-T +/- Consolidation 1 3
GU S2312 Pros, MCRPC, Cab +/- Carb 1 3